Access cutting-edge early alzheimer's disease treatment through this clinical trial at a research site in Inglewood. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Inglewood location
Access early alzheimer's disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related early alzheimer's disease treatment provided free
Check if you qualify for this early alzheimer's disease clinical trial in Inglewood, CA
No-Cost Study Care
Local to Inglewood
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Researchers want to know if the study treatment called MK-2214 works to slow certain changes in the brains of people with Alzheimer's disease (AD). AD is a type of dementia that can cause loss of memory, communication (such as speech), and decision-making skills. It can limit a person's ability to do daily tasks. MK-2214 is a study treatment designed to slow down AD. The goals of the study are to learn: * If MK-2214 slows the spread of tau in the brain compared to placebo. Tau is a protein tha
Sponsor: Merck Sharp & Dohme LLC
Yes, this clinical trial (NCT07033494) has an active research site in Inglewood, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for early alzheimer's disease treatment options in Inglewood, CA, this clinical trial (NCT07033494) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Inglewood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced early alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all early alzheimer's disease clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Inglewood — not just this study.
Browse Alzheimers Disease Trials in Inglewood →